Beijing Andawell Science & Technology Co., Ltd. (SHE:300719)
20.89
+3.48 (19.99%)
Feb 13, 2026, 3:04 PM CST
SHE:300719 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
| 713.97 | 632.79 | 850.86 | 412.55 | 475.46 | 609.7 | |
Revenue Growth (YoY) | -10.97% | -25.63% | 106.25% | -13.23% | -22.02% | 10.36% |
Cost of Revenue | 432.71 | 374.69 | 471.27 | 252.93 | 256.89 | 305.71 |
Gross Profit | 281.26 | 258.1 | 379.59 | 159.61 | 218.57 | 303.99 |
Selling, General & Admin | 177.8 | 171.07 | 173.69 | 153.55 | 151.35 | 138.49 |
Research & Development | 87.95 | 82.2 | 66.68 | 69.49 | 70.16 | 83.68 |
Other Operating Expenses | 2.97 | -11.8 | -3.68 | -14.53 | -7.9 | -25.73 |
Operating Expenses | 269.07 | 247.41 | 250.9 | 224.01 | 210.34 | 204.96 |
Operating Income | 12.2 | 10.69 | 128.69 | -64.4 | 8.22 | 99.03 |
Interest Expense | -10.14 | -7.25 | -4.12 | -3.11 | -4.37 | -6 |
Interest & Investment Income | 1.12 | 1.8 | 2.42 | 1.67 | 1.55 | 0.82 |
Currency Exchange Gain (Loss) | 0 | 0 | 0.02 | 0 | -0.01 | 0 |
Other Non Operating Income (Expenses) | -2.01 | -2.35 | -1.4 | -0.48 | -0.62 | -0.33 |
EBT Excluding Unusual Items | 1.16 | 2.89 | 125.61 | -66.3 | 4.77 | 93.53 |
Gain (Loss) on Sale of Investments | 0 | 0 | -0.01 | - | -1.2 | -0.76 |
Gain (Loss) on Sale of Assets | -0.17 | 4.94 | -0.21 | 0.48 | -0.04 | 0.02 |
Asset Writedown | 0.44 | -0.22 | -0.09 | -0.3 | -0.14 | -0.33 |
Other Unusual Items | -0.96 | -2.36 | -0.4 | 3.53 | 0.95 | 10.52 |
Pretax Income | 0.47 | 5.26 | 124.9 | -62.58 | 4.34 | 102.99 |
Income Tax Expense | -6.19 | -7.45 | 11.41 | -16.77 | -6.09 | 7.51 |
Earnings From Continuing Operations | 6.66 | 12.7 | 113.49 | -45.82 | 10.43 | 95.48 |
Minority Interest in Earnings | 2.44 | 1.12 | -0.01 | - | - | - |
Net Income | 9.11 | 13.83 | 113.48 | -45.82 | 10.43 | 95.48 |
Net Income to Common | 9.11 | 13.83 | 113.48 | -45.82 | 10.43 | 95.48 |
Net Income Growth | -90.86% | -87.81% | - | - | -89.08% | 30.53% |
Shares Outstanding (Basic) | 257 | 255 | 255 | 254 | 254 | 254 |
Shares Outstanding (Diluted) | 257 | 255 | 255 | 254 | 254 | 254 |
Shares Change (YoY) | 0.55% | -0.05% | 0.34% | 0.04% | 0.01% | 0.18% |
EPS (Basic) | 0.04 | 0.05 | 0.44 | -0.18 | 0.04 | 0.38 |
EPS (Diluted) | 0.04 | 0.05 | 0.44 | -0.18 | 0.04 | 0.38 |
EPS Growth | -90.91% | -87.81% | - | - | -89.08% | 30.29% |
Free Cash Flow | -115.39 | -270.91 | 12.01 | -36.6 | 119.55 | -31.78 |
Free Cash Flow Per Share | -0.45 | -1.06 | 0.05 | -0.14 | 0.47 | -0.13 |
Dividend Per Share | 0.040 | 0.040 | 0.200 | - | 0.020 | 0.200 |
Dividend Growth | -80.00% | -80.00% | - | - | -90.00% | 100.00% |
Gross Margin | 39.39% | 40.79% | 44.61% | 38.69% | 45.97% | 49.86% |
Operating Margin | 1.71% | 1.69% | 15.13% | -15.61% | 1.73% | 16.24% |
Profit Margin | 1.27% | 2.19% | 13.34% | -11.11% | 2.19% | 15.66% |
Free Cash Flow Margin | -16.16% | -42.81% | 1.41% | -8.87% | 25.14% | -5.21% |
EBITDA | 29.31 | 26.23 | 142.13 | -47.68 | 23.65 | 114.61 |
EBITDA Margin | 4.11% | 4.15% | 16.70% | -11.56% | 4.97% | 18.80% |
D&A For EBITDA | 17.11 | 15.54 | 13.44 | 16.72 | 15.43 | 15.58 |
EBIT | 12.2 | 10.69 | 128.69 | -64.4 | 8.22 | 99.03 |
EBIT Margin | 1.71% | 1.69% | 15.13% | -15.61% | 1.73% | 16.24% |
Effective Tax Rate | - | - | 9.14% | - | - | 7.29% |
Revenue as Reported | 713.97 | 632.79 | 850.86 | 412.55 | 475.46 | 609.7 |
Advertising Expenses | - | 1.65 | 1.24 | 0.23 | 0.92 | 0.75 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.